Professor Gary Evans
Professor Gary Evans is deputy director of the Ferrier Research Institute at Victoria University. His research involves designing and synthesising enzyme inhibitors for treating disease. He invented Ulodesine which completed Phase II clinical trials for the treatment of gout. Currently his work is focused on the development of new antibiotic and antiviral drugs.
Professor Evans did his PhD at Otago University, a postdoc at Oxford University and then worked in the biotechnology sector within the United Kingdom. He was appointed a Member of NZ Order of Merit in 2014 and has received several awards, including the 2014 Janssen Best Innovation Award and the 2011 MacDiarmid Medal from the Royal Society of New Zealand.
ORCID ID: 0000-0002-6973-2002